Recent Finacing
Recent Raise
Aerpio Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule Tie2 activators and HIF-1α stabilizers, including AKB-9778 for diabetic macular edema and AKB-4924 for inflammatory bowel disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors